Fulltext

The use of paclitaxel coated balloon (PCB) in acute coronary syndrome of small vessel de novo lesions: an analysis of a prospective 'real world' registry

Mahmood Zuhdi AS 1 , Zeymer U 2 , Waliszewski M 3 , Spiecker M 4 , Ismail MD 1 , Boxberger M 3 Show all authors , Ferrari M 5 , Zainal Abidin I 1 , Wan Ahmad WA 1

Affiliations 

  • 1 Cardiology Unit, University Malaya Medical Centre, 59100 Kuala Lumpur, Malaysia
  • 2 Klinikum der Stadt Ludwigshafen am Rhein, Bremserstrasse 79, 67063 Ludwigshafen, Germany
  • 3 Medical Scientific Affairs, B. Braun Melsungen AG, Melsungen, Germany
  • 4 Klinik fur Kardiologie, Marien Hospital Marl, Marl, Germany
  • 5 Klinik fur Innere Medizin I, Universitatsklinikum Jena, Jena, Germany
Springerplus, 2016;5:373.
PMID: 27066381 DOI: 10.1186/s40064-016-2014-y

Abstract

Paclitaxel-coated balloon (PCB) angioplasty in small vessel de novo lesions has favourable outcome and appears to be an alternative to stent implantation. However there is limitted data on its use specifically in small vessel acute coronary syndrome (ACS).

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications